23andMe Holding Co. (ME) FinancialsME23andMe Holding Co.

23andMe Holding Co. (ME) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumer services, accounting for 78.4% of total sales, equivalent to $35.08M. Other significant revenue streams include Telehealth and Research services. Understanding this composition is critical for investors evaluating how ME navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, 23andMe Holding Co. maintains a gross margin of 66.09%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -29.42%, while the net margin is -44.43%. These profitability ratios, combined with a Return on Equity (ROE) of -150.73%, provide a clear picture of how effectively ME converts its operational activities into shareholder value.

In the context of the broader market, ME competes directly with industry leaders such as IMNN and INAB. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, ME's gross margin of 66.09% stands against IMNN's N/A and INAB's N/A. Such benchmarking helps identify whether 23andMe Holding Co. is trading at a premium or discount relative to its financial performance.